X-154428787-T-TGGCGGC
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001183.6(ATP6AP1):c.111_116dup(p.Ala40_Ala41dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0131 in 1,124,353 control chromosomes in the GnomAD database, including 1,267 homozygotes. There are 3,562 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.071 ( 735 hom., 2048 hem., cov: 21)
Exomes 𝑓: 0.0066 ( 532 hom. 1514 hem. )
Consequence
ATP6AP1
NM_001183.6 inframe_insertion
NM_001183.6 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.146
Genes affected
ATP6AP1 (HGNC:868): (ATPase H+ transporting accessory protein 1) This gene encodes a component of a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. Vacuolar ATPase (V-ATPase) is comprised of a cytosolic V1 (site of the ATP catalytic site) and a transmembrane V0 domain. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, and receptor-mediated endocytosis. The encoded protein of this gene may assist in the V-ATPase-mediated acidification of neuroendocrine secretory granules. This protein may also play a role in early development. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant X-154428787-T-TGGCGGC is Benign according to our data. Variant chrX-154428787-T-TGGCGGC is described in ClinVar as [Benign]. Clinvar id is 1165872.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.242 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP6AP1 | NM_001183.6 | c.111_116dup | p.Ala40_Ala41dup | inframe_insertion | 1/10 | ENST00000369762.7 | NP_001174.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP6AP1 | ENST00000369762.7 | c.111_116dup | p.Ala40_Ala41dup | inframe_insertion | 1/10 | 1 | NM_001183.6 | ENSP00000358777 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0710 AC: 7960AN: 112046Hom.: 735 Cov.: 21 AF XY: 0.0590 AC XY: 2030AN XY: 34410
GnomAD3 genomes
AF:
AC:
7960
AN:
112046
Hom.:
Cov.:
21
AF XY:
AC XY:
2030
AN XY:
34410
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00470 AC: 256AN: 54469Hom.: 14 AF XY: 0.00220 AC XY: 32AN XY: 14567
GnomAD3 exomes
AF:
AC:
256
AN:
54469
Hom.:
AF XY:
AC XY:
32
AN XY:
14567
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00662 AC: 6697AN: 1012267Hom.: 532 Cov.: 31 AF XY: 0.00465 AC XY: 1514AN XY: 325735
GnomAD4 exome
AF:
AC:
6697
AN:
1012267
Hom.:
Cov.:
31
AF XY:
AC XY:
1514
AN XY:
325735
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0712 AC: 7978AN: 112086Hom.: 735 Cov.: 21 AF XY: 0.0594 AC XY: 2048AN XY: 34460
GnomAD4 genome
AF:
AC:
7978
AN:
112086
Hom.:
Cov.:
21
AF XY:
AC XY:
2048
AN XY:
34460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 13, 2019 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 19, 2021 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at